HomeCompareEWOOF vs MRK

EWOOF vs MRK: Dividend Comparison 2026

EWOOF yields 288.31% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EWOOF wins by $1160.72M in total portfolio value
10 years
EWOOF
EWOOF
● Live price
288.31%
Share price
$0.69
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1160.78M
Annual income
$689,991,475.77
Full EWOOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EWOOF vs MRK

📍 EWOOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEWOOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EWOOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EWOOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EWOOF
Annual income on $10K today (after 15% tax)
$24,506.27/yr
After 10yr DRIP, annual income (after tax)
$586,492,754.40/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EWOOF beats the other by $586,484,425.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EWOOF + MRK for your $10,000?

EWOOF: 50%MRK: 50%
100% MRK50/50100% EWOOF
Portfolio after 10yr
$580.42M
Annual income
$345,000,636.95/yr
Blended yield
59.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EWOOF
No analyst data
Altman Z
-5.5
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EWOOF buys
0
MRK buys
0
No recent congressional trades found for EWOOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEWOOFMRK
Forward yield288.31%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1160.78M$56.8K
Annual income after 10y$689,991,475.77$9,798.13
Total dividends collected$1112.94M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EWOOF vs MRK ($10,000, DRIP)

YearEWOOF PortfolioEWOOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$39,531$28,830.91$11,206$366.19+$28.3KEWOOF
2$148,813$106,515.13$12,650$502.35+$136.2KEWOOF
3$533,972$374,741.85$14,407$694.19+$519.6KEWOOF
4$1,828,032$1,256,682.11$16,585$967.82+$1.81MEWOOF
5$5,976,744$4,020,749.48$19,342$1,363.89+$5.96MEWOOF
6$18,680,933$12,285,817.42$22,913$1,947.19+$18.66MEWOOF
7$55,877,008$35,888,409.04$27,662$2,823.89+$55.85MEWOOF
8$160,112,435$100,324,036.73$34,159$4,173.35+$160.08MEWOOF
9$439,986,573$268,666,267.61$43,337$6,308.80+$439.94MEWOOF
10$1,160,777,109$689,991,475.77$56,776$9,798.13+$1160.72MEWOOF

EWOOF vs MRK: Complete Analysis 2026

EWOOFStock

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.

Full EWOOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EWOOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EWOOF vs SCHDEWOOF vs JEPIEWOOF vs OEWOOF vs KOEWOOF vs MAINEWOOF vs JNJEWOOF vs ABBVEWOOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.